HGH (176-191)

HGH Fragment (176-191)

HGH Fragment 176-191, a modified form of amino acids 176-191 of the Growth Hormone (GH) polypeptide, was discovered by investigators at Monash University to significantly impact fat reduction. Specifically, this small region near one end of the GH molecule, which consists of amino acids 176-191, appears to control these effects. Notably, this fragment represents less than 10% of the total size of the GH molecule and does not influence growth or insulin resistance. Instead, it mimics the natural regulation of fat metabolism by Growth Hormone without adverse effects on blood sugar or growth. Consequently, HGH Fragment 176-191 stimulates lipolysis and inhibits lipogenesis in both laboratory tests and in vivo studies involving animals and humans.

Fragment 176-191 as an Active HGH Truncated Sequence Peptide

The hgH ‘fragment 176-191’ is an analog to the growth hormone-releasing factor (GRF) which is responsible for signaling the effect of growth hormone. This further constitutes a 15-mer pep tide which corresponds to the C-terminus of-r hGH while the terminal contains an added tyrosine. The hormone synthetically manufactured is usually used by weight lifters and bodybuilders due to several advantages in physique. Most of the studies claimed that it in fact does help in decreasing the excess deposits of fat in places such as the abdomen, increasing the that it increases the muscle mass of the individuals and the fat presents in the body.

Such sections of the synthetic peptide hgH 176-191 have been studied for in vivo effects in laboratory mice musculus. Research results gave evidence that the fragments hgH 176-191 induced a temporary spike in the blood glucose concentration whereas plasma insulin increased and stayed raised significantly long with other fragments like 172-191, 177-191, and 178-191. Moreover, the researchers have provoked that the activity of the peptide lies not only in the information contained in the sequence but also in the correct spatial arrangement of the peptide (Ng and Borstein, 1978). By the same token, this fragment being a cleavage-fragment of pro-b5 deficient strain, and a region of protease superstructure, has been shown to promote the structural motion of cytoplasmic domain of epithelial membranous protein band 3, acting as a transverse connection between sub portions of two domains and helping to rotate two domain structures. In this case, such residue is very relevant to biological activity as discrete regions may represent sites for peripheral protein binding in some cells during the process of cellular morphogenesis for instance (Low et al. 1984).

In yet another study by Ng et al., Ng et al. (2000) conducted on animals, it was pointed out that 500mcg of the hormone would be sufficient to Lipolytic activity in the adipose tissues without affecting the blood glucose concentrations. In addition to these effects, this compound acts similarly to human growth hormone, but does not cause hyperglycemia, because it does not interact with the related hormonal receptors (Wu et al. 1993). This is the reason why experts have proposed the application of this drug for the purpose of targeting excess visceral fat, which is far more expressed in HIV-associated lipodystrophy.

The (hgH fragment 176-191) appears to be able to get rid of adipose tissue that has resisted all other methods but increase the waste of energy, level of muscle mass and oxidation of fatbody. All studies have pointed to the fact the the fragment is effective in obesity and fat loss cure and is way safer than its Human Growth Hormone counterpart.

Ask Price